Author:
Wang Zhonglei,Wang Ning,Yang Liyan,Song Xian-qing
Abstract
The devastating COVID-19 pandemic has caused more than six million deaths worldwide during the last 2 years. Effective therapeutic agents are greatly needed, yet promising magic bullets still do not exist. Numerous natural products (cordycepin, gallinamide A, plitidepsin, telocinobufagin, and tylophorine) have been widely studied and play a potential function in treating COVID-19. In this paper, we reviewed published studies (from May 2021 to April 2022) relating closely to bioactive natural products (isolated from medicinal plants, animals products, and marine organisms) in COVID-19 therapy in vitro to provide some essential guidance for anti-SARS-CoV-2 drug research and development.
Subject
Pharmacology (medical),Pharmacology
Reference123 articles.
1. Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections;Abdelmohsen;Lancet. Infect. Dis.,2017
2. Traditional herbal medicines, bioactive metabolites, and plant products against COVID-19: Update on clinical trials and mechanism of actions;Alam;Front. Pharmacol.,2021
3. Neoechinulin A as a promising SARS-CoV-2 Mpro inhibitor: In vitro and in silico study showing the ability of simulations in discerning active from inactive enzyme inhibitors;Alhadrami;Mar. Drugs,2022
4. The vital role of animal, marine, and microbial natural products against COVID-19;Alqathama;Pharm. Biol.,2022
5. Alkaloids from Cynanchum komarovii with inhibitory activity against the tobacco mosaic virus;An;Phytochemistry,2001
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献